Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CEL-SCI Corp CVM

Healthcare Biotechnology
CEL-SCI Corporation is a clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system. The Company is focused on the development of product candidates and technologies, such as Multikine, an investigational immunotherapy under development for the potential treatment of certain head and neck... see more

Recent & Breaking News (NYSEAM:CVM)

CEL-SCI Corporation's Manufacturing and Laboratory Operations Deemed Compliant with GMP Requirements Following Audit by European Union Qualified Person for a Second Time

Business Wire September 9, 2013

CEL-SCI Announces That NYSE MKT Approves Plan

Business Wire September 3, 2013

CEL-SCI Corporation Reports Third Quarter 2013 Financial Results

Business Wire August 9, 2013

Discounted Price Levels Make CEL-SCI Shares a Solid Speculative "Buy" Bet

Marketwired August 1, 2013

CEL-SCI and NIAID Publish Data Showing That CEL-SCI's LEAPS Technology Halted Progression of Lethal Influenza in Three Different Influenza Virus Strains, Including a Drug-Resistant and a 2009 Pandemic Flu Strain

Business Wire July 25, 2013

CEL-SCI Reports on NYSE MKT Noncompliance Notice and Compliance Plan

Business Wire July 19, 2013

RDInvesting Provides Investors with Free In-Depth Equity Reports on ACCO, CVM, DANG and SLXP

Accesswire July 8, 2013

CEL-SCI Corporation Announces Results of Annual Shareholders' Meeting and Adjournment of Meeting to July 25, 2013 with Respect to Proposal Concerning Stock Option Plan

Business Wire June 26, 2013

CEL-SCI Corporation To Present At The Second Annual Marcum LLP MicroCap Conference

PR Newswire May 23, 2013

CEL-SCI Corporation Reports Second Quarter 2013 Financial Results

Business Wire May 10, 2013

CEL-SCI Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Score in a Second Animal Model

Business Wire May 6, 2013

CEL-SCI To Present at the American Association of Immunologists 100th Annual Meeting on Saturday May 4th

Business Wire May 3, 2013

InvestorsGuru.com 47 Filtered Mid-Day Market Movers Recap

Investors Guru April 28, 2013

Bullish $10 Million Bet Placed by CRO After CEL-SCI Acts to Accelerate Phase III Enrollment

Marketwired April 24, 2013

CEL-SCI Corporation Provides Update on Phase III Clinical Trial

Business Wire April 23, 2013

CEL-SCI Corporation Announces That NIAID Collaborators Have Submitted Bird Flu Study for Publication to Prestigious Scientific Journal

Business Wire April 8, 2013

CEL-SCI's Price Rebound Looks Strong

Marketwired April 4, 2013

Taglich Brothers Initiates Coverage on CEL-SCI Corporation

Marketwired March 4, 2013

CEL-SCI Announces Initiation of New Sites for Multikine Phase III Clinical Study for Head and Neck Cancer in Taiwan

Business Wire February 25, 2013

CEL-SCI Corporation Reports First Quarter 2013 Financial Results

Business Wire February 8, 2013